Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
2336805, GSK2336805
print preview
bookmark
share with colleague
General Information
Company
GlaxoSmithKline plc
Description
HCV NS5A protein inhibitor
Molecular Target
HCV NS5A protein
Mechanism of Action
HCV non-structural protein 5A inhibitor
Latest Stage of Development
Phase II
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy